showed that inhibiting LSD1 in tumor cells promoted TP53-mediated transcriptional activation of genes, which leads to increased expression of Fas on the tumor cell surface, allowing FasL on CAR T cells to bind to Fas on the surface of tumor cells lacking antigen expression, thereby lysing and killing tumor cells (99). Here, TP53 is linked to neoplasm.